» Articles » PMID: 38147275

SPAG6 Regulates Cell Proliferation and Apoptosis Via TGF-β/Smad Signal Pathway in Adult B-cell Acute Lymphoblastic Leukemia

Overview
Journal Int J Hematol
Specialty Hematology
Date 2023 Dec 26
PMID 38147275
Authors
Affiliations
Soon will be listed here.
Abstract

Adult B-cell acute lymphoblastic leukemia (B-ALL) prognosis remains unsatisfactory, and searching for new therapeutic targets is crucial for improving patient prognosis. Sperm-associated antigen 6 (SPAG6), a member of the cancer-testis antigen family, plays an important role in tumors, especially hematologic tumors; however, it is unknown whether SPAG6 plays a role in adult B-ALL. In this study, we demonstrated for the first time that SPAG6 expression was up-regulated in the bone marrow of adult B-ALL patients compared to healthy donors, and expression was significantly reduced in patients who achieved complete remission (CR) after treatment. In addition, patients with high SPAG6 expression were older (≥ 35 years; P = 0.015), had elevated white blood cell counts (WBC > 30 × 10/L; P = 0.021), and a low rate of CR (P = 0.036). We explored the SPAG6 effect on cell function by lentiviral transfection of adult B-ALL cell lines BALL-1 and NALM-6, and discovered that knocking down SPAG6 significantly inhibited cell proliferation and promoted apoptosis. We identified that SPAG6 knockdown might regulate cell proliferation and apoptosis via the transforming growth factor-β (TGF-β)/Smad signaling pathway.

Citing Articles

Mechanism of THBS1 Regulation of MDCK Cell Proliferation and Apoptosis Through TGF-β/Smad Signalling.

Li R, Zhang F, Wang L, Wang S, Zhou M, Wang J Int J Mol Sci. 2025; 26(1.

PMID: 39796249 PMC: 11720202. DOI: 10.3390/ijms26010395.


A comprehensive pan-cancer analysis revealing as a novel diagnostic, prognostic and immunological biomarker in tumor.

Li X, Wang Y, Li X, Kong L, Diez J, Wang H Gland Surg. 2024; 13(6):999-1015.

PMID: 39015705 PMC: 11247597. DOI: 10.21037/gs-24-157.

References
1.
Cortes-Lopez M, Schulz L, Enculescu M, Paret C, Spiekermann B, Quesnel-Vallieres M . High-throughput mutagenesis identifies mutations and RNA-binding proteins controlling CD19 splicing and CART-19 therapy resistance. Nat Commun. 2022; 13(1):5570. PMC: 9500061. DOI: 10.1038/s41467-022-31818-y. View

2.
Jabbour E, OBrien S, Konopleva M, Kantarjian H . New insights into the pathophysiology and therapy of adult acute lymphoblastic leukemia. Cancer. 2015; 121(15):2517-28. PMC: 11726371. DOI: 10.1002/cncr.29383. View

3.
Malard F, Mohty M . Acute lymphoblastic leukaemia. Lancet. 2020; 395(10230):1146-1162. DOI: 10.1016/S0140-6736(19)33018-1. View

4.
Rowe J, Buck G, Burnett A, Chopra R, Wiernik P, Richards S . Induction therapy for adults with acute lymphoblastic leukemia: results of more than 1500 patients from the international ALL trial: MRC UKALL XII/ECOG E2993. Blood. 2005; 106(12):3760-7. DOI: 10.1182/blood-2005-04-1623. View

5.
Pulte D, Gondos A, Brenner H . Improvement in survival in younger patients with acute lymphoblastic leukemia from the 1980s to the early 21st century. Blood. 2008; 113(7):1408-11. DOI: 10.1182/blood-2008-06-164863. View